Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie

AstraZeneca (AZN) Set to Acquire Gracell for $1.2 Billion

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Gracell, for a total deal value of up to $1.2 billion.…

AstraZeneca-Aktie: AstraZeneca übernimmt Gracell Biotechnologies für einen Milliardenbetrag

Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…

AstraZeneca set to make one of its first acquisitions in China

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…

AstraZeneca-Aktie: AstraZeneca übernmmt Gracell Biotechnologies für einen Milliardenbetrag

Wie der Konzern mitteilte, wird Gracell Biotechnologies für einen Gesamtwert von 1,2 Milliarden US-Dollar übernommen. Der Baranteil liege bei der…

Wall Street Breakfast Podcast: AstraZeneca To Buy Gracell Biotechnologies

…

AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals

…

AstraZeneca to buy Gracell Biotechnologies for $1.2 billion

…

AstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion

…

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases…

Global Injection Pen Market Analysis and Forecast to 2028, Featuring Analysis of Key Players Sanofi, Eli Lilly, Novo Nordisk, Becton Dickinson, AstraZeneca, F. Hoffmann-La Roche & Merck

Dublin, Dec. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Injection Pen Market: Analysis By Type, By Therapy, By…

Wainua (eplontersen) granted first US FDA approval

22 December 2023 Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated…

Ionis Pharmaceuticals, AstraZeneca get FDA approval for rare genetic disease treatment

Ionis Pharmaceuticals and AstraZenecas Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of…

Pharma Stock Roundup: FDA Nod to AZNs Eplontersen, CRL to MRKs Cough Candidate

FDA approves AstraZeneca (AZN) and Ionis (IONS) Wainua (eplontersen) for ATTRv-PN and gives CRL to Mercks chronic cough candidate, gefapixant.…

Ionis (IONS), AstraZenecas Eplontersen Receives FDA Nod

FDA approves Ionis (IONS) and partner AstraZenecas (AZN) Wainua for treating ATTRv-PN. Ionis stock rises on this important milestone.…

Global Biologics Drug Discovery Market Analysis, 2023-2033: Dominated by AbbVie, Amgen, AstraZeneca, and Pfizer

Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis,…

Lloyds, AstraZeneca, BATs, Rolls-Royce: Whats on the menu for 2024?

For investors, the focus in 2024 will be on navigating a year expected to be split into distinct halves. That,…

Assemblin performs extensive multidisciplinary project for AstraZeneca

Assemblin has been commissioned to perform and coordinate multidisciplinary technical installations in the areas of electricity, ventilation, cooling and heating…

Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More

Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.…

Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added…

Atlas Copco Group appoints new Media Relations Manager

Nacka, Sweden, December 14, 2023: Atlas Copco Group has appointed Christina Malmberg Hägerstrand as its new Media Relations Manager. Christina Malmberg…

The Zacks Analyst Blog Highlights Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources

Adobe, AstraZeneca, Intel, Morgan Stanley and EOG Resources are part of the Zacks top Analyst Blog.…

AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition

…

AstraZeneca verkündet Milliardenübernahme - Hannover Rück erhöht Ziele

Der Pharmakonzern AstraZeneca erweitert Produktportfolio durch den Zukauf von Icosavax für einen Milliardenbetrag. Hannover Rück hebt die Wachstumsziele für die…

NASDAQ-Titel Icosavax-Aktie +48 %: AstraZeneca kauft Icosavax für Milliardenbetrag - AstraZeneca-Aktie gewinnt

Für bis zu 1,1 Milliarden US-Dollar übernimmt AstraZeneca das US-Biopharma-Unternehmen Icosavax. Damit will Astrazeneca seine Impfstoff- und Immuntherapien-Pipeline ...…

Gastroesophageal Reflux Disease Market to Grow at a Substantial Growth Rate by 2032 - DelveInsight | Key Companies in the Market - Phathom Pharmaceuticals, Microbiome Health Sciences, Takeda, Braintree Laboratories, AstraZeneca

The gastroesophageal reflux disease market is expected to show positive growth, mainly attributed to increased prevalence and the expected launch…

AstraZeneca Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…

Icosavax surges 45% in pre-market trading as AstraZeneca agrees takeover

Vaccines specialist Icosavax Inc (NASDAQ: ICVX) is set to surge 45% on Tuesday after agreeing to be taken over by Anglo-Swedish…

UBS belässt Astrazeneca auf Buy - Ziel 13000 Pence

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Astrazeneca mit einem Kursziel von 13000 Pence auf "Buy" belassen. Mit…

AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal (NASDAQ:AZN)

In a bid to strengthen its respiratory syncytial virus (RSV) vaccine portfolio, AstraZeneca (NASDAQ:AZN) has agreed to acquire U.S. vaccine…

AstraZeneca to acquire vaccine maker Icosavax in ~$1.1B deal

…

Icosavax enters agreement to be acquired by Astrazeneca

…

AstraZeneca to buy U.S.-based Icosavax for up to $1.1 billion

AstraZeneca to buy U.S.-based Icosavax for up to $1.1 billion…

AstraZeneca to Buy Icosavax for Up to $1.1 Bln

…

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca

Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca…

AstraZeneca to acquire Icosavax

News Release Regulatory News Service 12 December 2023 AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase…

Drugmaker investing $228 million, adding hundreds of new jobs in Cincinnati

The company has secured multiple new agreements since it bought AstraZenecas 580,000-square-foot West Chester facility.…

AstraZeneca (AZN) to Acquire Vaccine Maker Icosavax for $1.1B

AstraZeneca (AZN) is set to acquire clinical-stage biopharmaceutical company, Icosavax, for a total deal value of up to $1.1 billion.…

AstraZeneca Is Feeling The Weight Of The Market In 2023

…

AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?

Itll take a few years for its latest moves to pay off, assuming they do.…

CORRECTION: Newsletter December 2023 – Summing up the year with a Christmas message and Cline’s bright view of the future

In our Newsletter published on 7TH December 2023, a section was included related to AstraZeneca BioVentureHub. This was not officially…

dpa-AFX ProFeed